2023-2028 Global and Regional Tuberculosis Drug Industry Status and Prospects Professional Market Research Report Standard Version

August 2023 | 143 pages | ID: 253212683D68EN
HNY RESEARCH

Abstracts

The global Tuberculosis Drug market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
Lupin
Otsuka Novel Products
Pfizer
Sanofi

By Types:
First-line Anti-TB Drugs
Second-line Anti-TB Drugs

By Applications:
Active TB
Latent TB

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

Contents

CHAPTER 1 INDUSTRY OVERVIEW

1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
  1.4.1 North America Market States and Outlook (2023-2028)
  1.4.2 East Asia Market States and Outlook (2023-2028)
  1.4.3 Europe Market States and Outlook (2023-2028)
  1.4.4 South Asia Market States and Outlook (2023-2028)
  1.4.5 Southeast Asia Market States and Outlook (2023-2028)
  1.4.6 Middle East Market States and Outlook (2023-2028)
  1.4.7 Africa Market States and Outlook (2023-2028)
  1.4.8 Oceania Market States and Outlook (2023-2028)
  1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Tuberculosis Drug Market Size Analysis from 2023 to 2028
  1.5.1 Global Tuberculosis Drug Market Size Analysis from 2023 to 2028 by Consumption Volume
  1.5.2 Global Tuberculosis Drug Market Size Analysis from 2023 to 2028 by Value
  1.5.3 Global Tuberculosis Drug Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Tuberculosis Drug Industry Impact

CHAPTER 2 GLOBAL TUBERCULOSIS DRUG COMPETITION BY TYPES, APPLICATIONS, AND TOP REGIONS AND COUNTRIES

2.1 Global Tuberculosis Drug (Volume and Value) by Type
  2.1.1 Global Tuberculosis Drug Consumption and Market Share by Type (2017-2022)
  2.1.2 Global Tuberculosis Drug Revenue and Market Share by Type (2017-2022)
2.2 Global Tuberculosis Drug (Volume and Value) by Application
  2.2.1 Global Tuberculosis Drug Consumption and Market Share by Application (2017-2022)
  2.2.2 Global Tuberculosis Drug Revenue and Market Share by Application (2017-2022)
2.3 Global Tuberculosis Drug (Volume and Value) by Regions
  2.3.1 Global Tuberculosis Drug Consumption and Market Share by Regions (2017-2022)
  2.3.2 Global Tuberculosis Drug Revenue and Market Share by Regions (2017-2022)

CHAPTER 3 PRODUCTION MARKET ANALYSIS

3.1 Global Production Market Analysis
  3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
  3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
  3.2.1 2017-2022 Regional Market Performance and Market Share
  3.2.2 North America Market
  3.2.3 East Asia Market
  3.2.4 Europe Market
  3.2.5 South Asia Market
  3.2.6 Southeast Asia Market
  3.2.7 Middle East Market
  3.2.8 Africa Market
  3.2.9 Oceania Market
  3.2.10 South America Market
  3.2.11 Rest of the World Market

CHAPTER 4 GLOBAL TUBERCULOSIS DRUG SALES, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2017-2022)

4.1 Global Tuberculosis Drug Consumption by Regions (2017-2022)
4.2 North America Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
4.10 South America Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)

CHAPTER 5 NORTH AMERICA TUBERCULOSIS DRUG MARKET ANALYSIS

5.1 North America Tuberculosis Drug Consumption and Value Analysis
  5.1.1 North America Tuberculosis Drug Market Under COVID-19
5.2 North America Tuberculosis Drug Consumption Volume by Types
5.3 North America Tuberculosis Drug Consumption Structure by Application
5.4 North America Tuberculosis Drug Consumption by Top Countries
  5.4.1 United States Tuberculosis Drug Consumption Volume from 2017 to 2022
  5.4.2 Canada Tuberculosis Drug Consumption Volume from 2017 to 2022
  5.4.3 Mexico Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 6 EAST ASIA TUBERCULOSIS DRUG MARKET ANALYSIS

6.1 East Asia Tuberculosis Drug Consumption and Value Analysis
  6.1.1 East Asia Tuberculosis Drug Market Under COVID-19
6.2 East Asia Tuberculosis Drug Consumption Volume by Types
6.3 East Asia Tuberculosis Drug Consumption Structure by Application
6.4 East Asia Tuberculosis Drug Consumption by Top Countries
  6.4.1 China Tuberculosis Drug Consumption Volume from 2017 to 2022
  6.4.2 Japan Tuberculosis Drug Consumption Volume from 2017 to 2022
  6.4.3 South Korea Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 7 EUROPE TUBERCULOSIS DRUG MARKET ANALYSIS

7.1 Europe Tuberculosis Drug Consumption and Value Analysis
  7.1.1 Europe Tuberculosis Drug Market Under COVID-19
7.2 Europe Tuberculosis Drug Consumption Volume by Types
7.3 Europe Tuberculosis Drug Consumption Structure by Application
7.4 Europe Tuberculosis Drug Consumption by Top Countries
  7.4.1 Germany Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.2 UK Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.3 France Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.4 Italy Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.5 Russia Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.6 Spain Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.7 Netherlands Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.8 Switzerland Tuberculosis Drug Consumption Volume from 2017 to 2022
  7.4.9 Poland Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 8 SOUTH ASIA TUBERCULOSIS DRUG MARKET ANALYSIS

8.1 South Asia Tuberculosis Drug Consumption and Value Analysis
  8.1.1 South Asia Tuberculosis Drug Market Under COVID-19
8.2 South Asia Tuberculosis Drug Consumption Volume by Types
8.3 South Asia Tuberculosis Drug Consumption Structure by Application
8.4 South Asia Tuberculosis Drug Consumption by Top Countries
  8.4.1 India Tuberculosis Drug Consumption Volume from 2017 to 2022
  8.4.2 Pakistan Tuberculosis Drug Consumption Volume from 2017 to 2022
  8.4.3 Bangladesh Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 9 SOUTHEAST ASIA TUBERCULOSIS DRUG MARKET ANALYSIS

9.1 Southeast Asia Tuberculosis Drug Consumption and Value Analysis
  9.1.1 Southeast Asia Tuberculosis Drug Market Under COVID-19
9.2 Southeast Asia Tuberculosis Drug Consumption Volume by Types
9.3 Southeast Asia Tuberculosis Drug Consumption Structure by Application
9.4 Southeast Asia Tuberculosis Drug Consumption by Top Countries
  9.4.1 Indonesia Tuberculosis Drug Consumption Volume from 2017 to 2022
  9.4.2 Thailand Tuberculosis Drug Consumption Volume from 2017 to 2022
  9.4.3 Singapore Tuberculosis Drug Consumption Volume from 2017 to 2022
  9.4.4 Malaysia Tuberculosis Drug Consumption Volume from 2017 to 2022
  9.4.5 Philippines Tuberculosis Drug Consumption Volume from 2017 to 2022
  9.4.6 Vietnam Tuberculosis Drug Consumption Volume from 2017 to 2022
  9.4.7 Myanmar Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 10 MIDDLE EAST TUBERCULOSIS DRUG MARKET ANALYSIS

10.1 Middle East Tuberculosis Drug Consumption and Value Analysis
  10.1.1 Middle East Tuberculosis Drug Market Under COVID-19
10.2 Middle East Tuberculosis Drug Consumption Volume by Types
10.3 Middle East Tuberculosis Drug Consumption Structure by Application
10.4 Middle East Tuberculosis Drug Consumption by Top Countries
  10.4.1 Turkey Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.2 Saudi Arabia Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.3 Iran Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.4 United Arab Emirates Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.5 Israel Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.6 Iraq Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.7 Qatar Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.8 Kuwait Tuberculosis Drug Consumption Volume from 2017 to 2022
  10.4.9 Oman Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 11 AFRICA TUBERCULOSIS DRUG MARKET ANALYSIS

11.1 Africa Tuberculosis Drug Consumption and Value Analysis
  11.1.1 Africa Tuberculosis Drug Market Under COVID-19
11.2 Africa Tuberculosis Drug Consumption Volume by Types
11.3 Africa Tuberculosis Drug Consumption Structure by Application
11.4 Africa Tuberculosis Drug Consumption by Top Countries
  11.4.1 Nigeria Tuberculosis Drug Consumption Volume from 2017 to 2022
  11.4.2 South Africa Tuberculosis Drug Consumption Volume from 2017 to 2022
  11.4.3 Egypt Tuberculosis Drug Consumption Volume from 2017 to 2022
  11.4.4 Algeria Tuberculosis Drug Consumption Volume from 2017 to 2022
  11.4.5 Morocco Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 12 OCEANIA TUBERCULOSIS DRUG MARKET ANALYSIS

12.1 Oceania Tuberculosis Drug Consumption and Value Analysis
12.2 Oceania Tuberculosis Drug Consumption Volume by Types
12.3 Oceania Tuberculosis Drug Consumption Structure by Application
12.4 Oceania Tuberculosis Drug Consumption by Top Countries
  12.4.1 Australia Tuberculosis Drug Consumption Volume from 2017 to 2022
  12.4.2 New Zealand Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 13 SOUTH AMERICA TUBERCULOSIS DRUG MARKET ANALYSIS

13.1 South America Tuberculosis Drug Consumption and Value Analysis
  13.1.1 South America Tuberculosis Drug Market Under COVID-19
13.2 South America Tuberculosis Drug Consumption Volume by Types
13.3 South America Tuberculosis Drug Consumption Structure by Application
13.4 South America Tuberculosis Drug Consumption Volume by Major Countries
  13.4.1 Brazil Tuberculosis Drug Consumption Volume from 2017 to 2022
  13.4.2 Argentina Tuberculosis Drug Consumption Volume from 2017 to 2022
  13.4.3 Columbia Tuberculosis Drug Consumption Volume from 2017 to 2022
  13.4.4 Chile Tuberculosis Drug Consumption Volume from 2017 to 2022
  13.4.5 Venezuela Tuberculosis Drug Consumption Volume from 2017 to 2022
  13.4.6 Peru Tuberculosis Drug Consumption Volume from 2017 to 2022
  13.4.7 Puerto Rico Tuberculosis Drug Consumption Volume from 2017 to 2022
  13.4.8 Ecuador Tuberculosis Drug Consumption Volume from 2017 to 2022

CHAPTER 14 COMPANY PROFILES AND KEY FIGURES IN TUBERCULOSIS DRUG BUSINESS

14.1 Lupin
  14.1.1 Lupin Company Profile
  14.1.2 Lupin Tuberculosis Drug Product Specification
  14.1.3 Lupin Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Otsuka Novel Products
  14.2.1 Otsuka Novel Products Company Profile
  14.2.2 Otsuka Novel Products Tuberculosis Drug Product Specification
  14.2.3 Otsuka Novel Products Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Pfizer
  14.3.1 Pfizer Company Profile
  14.3.2 Pfizer Tuberculosis Drug Product Specification
  14.3.3 Pfizer Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Sanofi
  14.4.1 Sanofi Company Profile
  14.4.2 Sanofi Tuberculosis Drug Product Specification
  14.4.3 Sanofi Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)

CHAPTER 15 GLOBAL TUBERCULOSIS DRUG MARKET FORECAST (2023-2028)

15.1 Global Tuberculosis Drug Consumption Volume, Revenue and Price Forecast (2023-2028)
  15.1.1 Global Tuberculosis Drug Consumption Volume and Growth Rate Forecast (2023-2028)
  15.1.2 Global Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
15.2 Global Tuberculosis Drug Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
  15.2.1 Global Tuberculosis Drug Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
  15.2.2 Global Tuberculosis Drug Value and Growth Rate Forecast by Regions (2023-2028)
  15.2.3 North America Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.4 East Asia Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.5 Europe Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.6 South Asia Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.7 Southeast Asia Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.8 Middle East Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.9 Africa Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.10 Oceania Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
  15.2.11 South America Tuberculosis Drug Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Tuberculosis Drug Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
  15.3.1 Global Tuberculosis Drug Consumption Forecast by Type (2023-2028)
  15.3.2 Global Tuberculosis Drug Revenue Forecast by Type (2023-2028)
  15.3.3 Global Tuberculosis Drug Price Forecast by Type (2023-2028)
15.4 Global Tuberculosis Drug Consumption Volume Forecast by Application (2023-2028)
15.5 Tuberculosis Drug Market Forecast Under COVID-19

CHAPTER 16 CONCLUSIONS

Research Methodology

List Of Tables

LIST OF TABLES AND FIGURES
Figure Product Picture
Figure North America Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure United States Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Canada Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Mexico Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure East Asia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure China Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Japan Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Korea Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Europe Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Germany Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure UK Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure France Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Italy Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Russia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Spain Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Netherlands Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Switzerland Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Poland Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Asia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure India Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Pakistan Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Bangladesh Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Southeast Asia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Indonesia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Thailand Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Singapore Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Malaysia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Philippines Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Vietnam Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Myanmar Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Middle East Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Turkey Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Saudi Arabia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Iran Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure United Arab Emirates Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Israel Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Iraq Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Qatar Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Kuwait Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Oman Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Africa Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Nigeria Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure South Africa Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Egypt Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Algeria Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Oceania Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Australia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure New Zealand Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure South America Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Brazil Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Argentina Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Columbia Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Chile Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Venezuela Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Peru Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Puerto Rico Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Ecuador Tuberculosis Drug Revenue ($) and Growth Rate (2023-2028)
Figure Global Tuberculosis Drug Market Size Analysis from 2023 to 2028 by Consumption Volume
Figure Global Tuberculosis Drug Market Size Analysis from 2023 to 2028 by Value
Table Global Tuberculosis Drug Price Trends Analysis from 2023 to 2028
Table Global Tuberculosis Drug Consumption and Market Share by Type (2017-2022)
Table Global Tuberculosis Drug Revenue and Market Share by Type (2017-2022)
Table Global Tuberculosis Drug Consumption and Market Share by Application (2017-2022)
Table Global Tuberculosis Drug Revenue and Market Share by Application (2017-2022)
Table Global Tuberculosis Drug Consumption and Market Share by Regions (2017-2022)
Table Global Tuberculosis Drug Revenue and Market Share by Regions (2017-2022)
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Major Manufacturers Capacity and Total Capacity
Table 2017-2022 Major Manufacturers Capacity Market Share
Table 2017-2022 Major Manufacturers Production and Total Production
Table 2017-2022 Major Manufacturers Production Market Share
Table 2017-2022 Major Manufacturers Revenue and Total Revenue
Table 2017-2022 Major Manufacturers Revenue Market Share
Table 2017-2022 Regional Market Capacity and Market Share
Table 2017-2022 Regional Market Production and Market Share
Table 2017-2022 Regional Market Revenue and Market Share
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table 2017-2022 Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin
Figure 2017-2022 Capacity, Production and Growth Rate
Figure 2017-2022 Revenue, Gross Margin and Growth Rate
Table Global Tuberculosis Drug Consumption by Regions (2017-2022)
Figure Global Tuberculosis Drug Consumption Share by Regions (2017-2022)
Table North America Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table East Asia Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table Europe Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table South Asia Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table Southeast Asia Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table Middle East Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table Africa Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table Oceania Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Table South America Tuberculosis Drug Sales, Consumption, Export, Import (2017-2022)
Figure North America Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure North America Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table North America Tuberculosis Drug Sales Price Analysis (2017-2022)
Table North America Tuberculosis Drug Consumption Volume by Types
Table North America Tuberculosis Drug Consumption Structure by Application
Table North America Tuberculosis Drug Consumption by Top Countries
Figure United States Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Canada Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Mexico Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure East Asia Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure East Asia Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table East Asia Tuberculosis Drug Sales Price Analysis (2017-2022)
Table East Asia Tuberculosis Drug Consumption Volume by Types
Table East Asia Tuberculosis Drug Consumption Structure by Application
Table East Asia Tuberculosis Drug Consumption by Top Countries
Figure China Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Japan Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure South Korea Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Europe Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure Europe Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table Europe Tuberculosis Drug Sales Price Analysis (2017-2022)
Table Europe Tuberculosis Drug Consumption Volume by Types
Table Europe Tuberculosis Drug Consumption Structure by Application
Table Europe Tuberculosis Drug Consumption by Top Countries
Figure Germany Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure UK Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure France Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Italy Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Russia Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Spain Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Netherlands Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Switzerland Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Poland Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure South Asia Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure South Asia Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table South Asia Tuberculosis Drug Sales Price Analysis (2017-2022)
Table South Asia Tuberculosis Drug Consumption Volume by Types
Table South Asia Tuberculosis Drug Consumption Structure by Application
Table South Asia Tuberculosis Drug Consumption by Top Countries
Figure India Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Pakistan Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Bangladesh Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Southeast Asia Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure Southeast Asia Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table Southeast Asia Tuberculosis Drug Sales Price Analysis (2017-2022)
Table Southeast Asia Tuberculosis Drug Consumption Volume by Types
Table Southeast Asia Tuberculosis Drug Consumption Structure by Application
Table Southeast Asia Tuberculosis Drug Consumption by Top Countries
Figure Indonesia Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Thailand Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Singapore Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Malaysia Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Philippines Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Vietnam Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Myanmar Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Middle East Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure Middle East Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table Middle East Tuberculosis Drug Sales Price Analysis (2017-2022)
Table Middle East Tuberculosis Drug Consumption Volume by Types
Table Middle East Tuberculosis Drug Consumption Structure by Application
Table Middle East Tuberculosis Drug Consumption by Top Countries
Figure Turkey Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Saudi Arabia Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Iran Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure United Arab Emirates Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Israel Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Iraq Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Qatar Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Kuwait Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Oman Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Africa Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure Africa Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table Africa Tuberculosis Drug Sales Price Analysis (2017-2022)
Table Africa Tuberculosis Drug Consumption Volume by Types
Table Africa Tuberculosis Drug Consumption Structure by Application
Table Africa Tuberculosis Drug Consumption by Top Countries
Figure Nigeria Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure South Africa Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Egypt Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Algeria Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Algeria Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Oceania Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure Oceania Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table Oceania Tuberculosis Drug Sales Price Analysis (2017-2022)
Table Oceania Tuberculosis Drug Consumption Volume by Types
Table Oceania Tuberculosis Drug Consumption Structure by Application
Table Oceania Tuberculosis Drug Consumption by Top Countries
Figure Australia Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure New Zealand Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure South America Tuberculosis Drug Consumption and Growth Rate (2017-2022)
Figure South America Tuberculosis Drug Revenue and Growth Rate (2017-2022)
Table South America Tuberculosis Drug Sales Price Analysis (2017-2022)
Table South America Tuberculosis Drug Consumption Volume by Types
Table South America Tuberculosis Drug Consumption Structure by Application
Table South America Tuberculosis Drug Consumption Volume by Major Countries
Figure Brazil Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Argentina Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Columbia Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Chile Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Venezuela Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Peru Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Puerto Rico Tuberculosis Drug Consumption Volume from 2017 to 2022
Figure Ecuador Tuberculosis Drug Consumption Volume from 2017 to 2022
Lupin Tuberculosis Drug Product Specification
Lupin Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Otsuka Novel Products Tuberculosis Drug Product Specification
Otsuka Novel Products Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Pfizer Tuberculosis Drug Product Specification
Pfizer Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Sanofi Tuberculosis Drug Product Specification
Table Sanofi Tuberculosis Drug Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Figure Global Tuberculosis Drug Consumption Volume and Growth Rate Forecast (2023-2028)
Figure Global Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Table Global Tuberculosis Drug Consumption Volume Forecast by Regions (2023-2028)
Table Global Tuberculosis Drug Value Forecast by Regions (2023-2028)
Figure North America Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure North America Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure United States Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure United States Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Canada Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Canada Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Mexico Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Mexico Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure East Asia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure East Asia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure China Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure China Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Japan Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Japan Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure South Korea Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South Korea Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Europe Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Europe Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Germany Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Germany Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure UK Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure UK Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure France Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure France Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Italy Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Italy Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Russia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Russia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Spain Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Spain Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Netherlands Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Netherlands Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Swizerland Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Swizerland Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Poland Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Poland Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure South Asia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South Asia a Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure India Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure India Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Pakistan Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Pakistan Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Bangladesh Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Bangladesh Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Southeast Asia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Southeast Asia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Indonesia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Indonesia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Thailand Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Thailand Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Singapore Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Singapore Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Malaysia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Malaysia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Philippines Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Philippines Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Vietnam Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Vietnam Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Myanmar Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Myanmar Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Middle East Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Middle East Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Turkey Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Turkey Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Saudi Arabia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Saudi Arabia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Iran Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Iran Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure United Arab Emirates Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure United Arab Emirates Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Israel Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Israel Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Iraq Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Iraq Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Qatar Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Qatar Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Kuwait Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Kuwait Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Oman Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Oman Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Africa Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Africa Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Nigeria Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Nigeria Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure South Africa Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South Africa Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Egypt Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Egypt Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Algeria Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Algeria Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Morocco Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Morocco Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Oceania Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Oceania Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Australia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Australia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure New Zealand Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure New Zealand Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure South America Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure South America Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Brazil Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Brazil Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Argentina Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Argentina Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Columbia Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Columbia Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Chile Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Chile Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Venezuela Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Venezuela Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Peru Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Peru Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Puerto Rico Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Puerto Rico Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Figure Ecuador Tuberculosis Drug Consumption and Growth Rate Forecast (2023-2028)
Figure Ecuador Tuberculosis Drug Value and Growth Rate Forecast (2023-2028)
Table Global Tuberculosis Drug Consumption Forecast by Type (2023-2028)
Table Global Tuberculosis Drug Revenue Forecast by Type (2023-2028)
Figure Global Tuberculosis Drug Price Forecast by Type (2023-2028)
Table Global Tuberculosis Drug Consumption Volume Forecast by Application (2023-2028)